Researchers from The University of Manchester—in collaboration with the Universities of Granada, Lund, and Oslo—have ...
Astria advances innovative therapies for hereditary angioedema and atopic dermatitis. Strong cash position supports pivotal ...
Q4 2024 total revenues of $53.2 million, +17% compared to Q4 2023 Q4 2024 Fanapt® net product sales of $26.6 million, +18% compared to Q4 2023 Full year 2024 total ...
Researchers from Cologne, Bochum, Padova and Angers have discovered a novel connection between mitochondrial function, ...
Get Jubilant Agri & Consumer Products today's stock price, 52-week high, 52-week low, Jubilant Agri & Consumer Products quarterly results, share performance, financials, peer comparison, technicals, ...
THE government is seeking a US$5,31 million grant from the African Development Bank (AfDB) to support the development of the beef and leather value chain. The support is part of the Zimbabwe ...
Weeran Angus are heading into their 54th Bull Sale at 1pm on Tuesday, February 25, 2025, and they invite you to go and visit ...
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
The 5 mg Evrysdi tablet can either be swallowed whole or dispersed ... Evrysdi was granted PRIME designation by the European Medicines Agency (EMA) in 2018 and Orphan Drug Designation by the U.S. Food ...
PARIS, France I February 12, 2025 I GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
About 10 in 100 people are left-handed, but why? A new article highlights the crucial role of early brain development for ...
Ask the publishers to restore access to 500,000+ books. An icon used to represent a menu that can be toggled by interacting with this icon. A line drawing of the Internet Archive headquarters building ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results